In a recent published report, Kenneth Research has updated the market report for Metabolomics Market for 2021 till 2030. Report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In the view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to be regain 25% by the end of 2021- Positive Growth in the economic demand and supply.
U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Metabolomics Market products.
Download Sample of This Strategic Report:
https://www.kennethresearch.com/sample-request-10233544
Moreover, increasing expenditure on healthcare, backed by the need amongst individuals for quality healthcare services, is also anticipated to contribute to the market growth. According to the statistics by the World Bank, the current health expenditure (% of GDP) around the world increased from 9.08% in 2001 to 9.84% in 2018. Additionally, the current health expenditure per capita (current US$) increased from USD 492.99 in 2001 to USD 1110.84 in 2018. Moreover, growing concern for deaths caused due to various diseases and the need for treatment that can lower the crude death rate, which in the year 2019 recorded close to 7% (per 1000 people), are also anticipated to drive the market growth during the forecast period.
Metabolomics can be defined as the study of metabolites or low molecular weight molecules found inside the cells and the biological systems. This branch of science basically aims at the comparison finding out the differences between biological samples and is based on their metabolite profile. Metabolomics generally makes the use of analytical process like Chromatography, spectroscopy and multi variable analysis.
“Final Report will add the analysis of the impact of COVID-19 on this industry.”
The market of metabolomics is expected to increase in forecasted period due to increasing adoption of the technology to various fields such as toxicology, nutrigenomics, and Functional genomics. North America is having the largest share of market, Europe and Asia pacific follow It respectively.
The major driving factors of the market are the continuous research and development made in the field also the funding allotted by various government of different geographic regions, Rising popularity of personalized medicine and development in metabolite profiling is also contributing to its growth. It has got its application in several other lucrative industries such as agriculture, Biomarker discovery etc. Some of the challenges in the field are its complexity in holding and interpreting large amount of data, unavailability of complete metabolite libraries and lack of standardized people also adds to the challenges of the field.
The market of metabolomics is segmented on the basis of techniques used, and the various fields of application. Geographically the market is segmented into North America (US, Canada), Europe (UK, Italy, Spain, France, Germany, RoE), Asia-Pacific (India, Japan, Australia, China, Korea, RoAPAC) and Rest of World (Latin America, MENA and Africa). The key providers of metabolomics in the market include: Agilent technologies, Waters Corporation, Big medicine INC, Biocrates Life Sciences etc.
Download Sample of This Strategic Report:
https://www.kennethresearch.com/sample-request-10233544
Companies Profiled include
1. Agilent technologies
2. Big medicine INC.
3. Biocrates Life Sciences
4. Bio-Rad laboratories
5. Bruker Corporation
6. Chenomx
7. Danaher Corporation
8. Human Metabolomics Technologies, Inc.
9. LECO Corporation
10. Metabolon, Inc.
11. Shimadzu Corporation
12. Thermo Fisher Scientific Inc
13. Waters Corporation
14. Ingenuity systems
15. Metanomics heatlth
16. Molecular biometrics
17. Umetrics
18. Unilever
This Research Report covers
1. Historical data
2.Revenue forecasts, growth rates and CAGR upto 2028
3.Industry Analysis
4.Competitive Analysis
5. Key geographic growth data
Request for Complete Report:
https://www.kennethresearch.com/sample-request-10233544
About Kenneth Research:
Kenneth Research provides market research reports to different individuals, industries, associations and organizations with an aim of helping them to take prominent decisions. Our research library comprises of more than 10,000 research reports provided by more than 15 market research publishers across different industries. Our collection of market research solutions covers both macro level as well as micro level categories with relevant and suitable market research titles. As a global market research reselling firm, Kenneth Research provides significant analysis on various markets with pure business intelligence and consulting services on different industries across the globe. In addition to that, our internal research team always keep a track on the international and domestic market for any economic changes impacting the products’ demand, growth and opportunities for new and existing players.
Contact Us
Kenneth Research
Email: Sales@kennethresearch.com
Phone: +1 313 462 0609